Connection

ANN SCHEIMANN to Severity of Illness Index

This is a "connection" page, showing publications ANN SCHEIMANN has written about Severity of Illness Index.
Connection Strength

0.346
  1. Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis. J Pediatr Gastroenterol Nutr. 2024 Nov; 79(5):943-953.
    View in: PubMed
    Score: 0.132
  2. The full spectrum of hepatic steatosis in children. Clin Pediatr (Phila). 2015 Jun; 54(7):635-42.
    View in: PubMed
    Score: 0.067
  3. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012 Apr; 95(4):892-900.
    View in: PubMed
    Score: 0.055
  4. Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. Gastroenterology. 2020 11; 159(5):1731-1751.e10.
    View in: PubMed
    Score: 0.025
  5. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2017 12; 19(12):1751-1761.
    View in: PubMed
    Score: 0.020
  6. Predictors of severity in childhood pancreatitis: correlation with nutritional status and racial demographics. Pancreas. 2015 Apr; 44(3):401-3.
    View in: PubMed
    Score: 0.017
  7. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr. 2015 Mar; 60(3):396-404.
    View in: PubMed
    Score: 0.017
  8. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011 Apr 27; 305(16):1659-68.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.